These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
369 related articles for article (PubMed ID: 6272875)
1. Binding of vasoactive intestinal peptide and its stimulation of adenylate cyclase through two classes of receptors in rat liver membranes. Effects of 12 secretin analogues and 2 secretin fragments. Waelbroeck M; Robberecht P; De Neef P; Chatelain P; Christophe J Biochim Biophys Acta; 1981 Nov; 678(1):83-90. PubMed ID: 6272875 [TBL] [Abstract][Full Text] [Related]
2. Presence of vasoactive intestinal peptide receptors coupled to adenylate cyclase in rat lung membranes. Robberecht P; Chatelain P; De Neef P; Camus JC; Waelbroeck M; Christophe J Biochim Biophys Acta; 1981 Nov; 678(1):76-82. PubMed ID: 6118184 [TBL] [Abstract][Full Text] [Related]
3. Heart receptors for VIP, PHI and secretin are able to activate adenylate cyclase and to mediate inotropic and chronotropic effects. Species variations and physiopathology. Christophe J; Waelbroeck M; Chatelain P; Robberecht P Peptides; 1984; 5(2):341-53. PubMed ID: 6089134 [TBL] [Abstract][Full Text] [Related]
4. Comparison of VIP-secretin receptors in rat and human lung. Christophe J; Chatelain P; Taton G; Delhaye M; Waelbroeck M; Robberecht P Peptides; 1981; 2 Suppl 2():253-8. PubMed ID: 6123988 [TBL] [Abstract][Full Text] [Related]
5. Effects of PHI on vasoactive intestinal peptide receptors and adenylate cyclase activity in lung membranes. A comparison in man, rat, mouse and guinea pig. Robberecht P; Tatemoto K; Chatelain P; Waelbroeck M; Delhaye M; Taton G; De Neef P; Camus JC; Heuse D; Christophe J Regul Pept; 1982 Oct; 4(5):241-50. PubMed ID: 6294750 [TBL] [Abstract][Full Text] [Related]
6. Characterization of the VIP- and secretin-stimulated adenylate cyclase system from human lung. Taton G; Delhaye M; Camus JC; de Neef P; Chatelain P; Robberecht P; Christophe J Pflugers Arch; 1981 Sep; 391(3):178-82. PubMed ID: 6126856 [TBL] [Abstract][Full Text] [Related]
7. Characterization of secretin and vasoactive intestinal peptide receptors in rat pancreatic plasma membranes using the native peptides, secretin-(7-27) and five secretin analogues. Robberecht P; Waelbroeck M; Noyer M; Chatelain P; De Neef P; König W; Christophe J Digestion; 1982; 23(3):201-10. PubMed ID: 6286393 [TBL] [Abstract][Full Text] [Related]
8. [D-Phe4]peptide histidine-isoleucinamide ([D-Phe4]PHI), a highly selective vasoactive-intestinal-peptide (VIP) agonist, discriminates VIP-preferring from secretin-preferring receptors in rat pancreatic membranes. Robberecht P; Coy DH; De Neef P; Camus JC; Cauvin A; Waelbroeck M; Christophe J Eur J Biochem; 1987 Jun; 165(2):243-9. PubMed ID: 3036504 [TBL] [Abstract][Full Text] [Related]
9. Interaction of vasoactive intestinal peptide with a cell line (HeLa) derived from human carcinoma of the cervix: binding to specific sites and stimulation of adenylate cyclase. Prieto JC; Guerrero JM; de Miguel C; Goberna R Mol Cell Biochem; 1981 Jul; 37(3):167-76. PubMed ID: 6268963 [TBL] [Abstract][Full Text] [Related]
10. Interaction of vasoactive intestinal peptide (VIP) and N-terminally modified VIP analogs with rat pancreatic, hepatic and pituitary membranes. Robberecht P; Coy DH; De Neef P; Camus JC; Cauvin A; Waelbroeck M; Christophe J Eur J Biochem; 1986 Aug; 159(1):45-9. PubMed ID: 3017717 [TBL] [Abstract][Full Text] [Related]
11. Specific labelling by [125I]helodermin of high-affinity VIP receptors in rat liver membranes. Robberecht P; Waelbroeck M; de Neef P; Camus JC; Vandermeers A; Vandermeers-Piret MC; Christophe J FEBS Lett; 1984 Jun; 172(1):55-8. PubMed ID: 6329822 [TBL] [Abstract][Full Text] [Related]
12. Importance of disulfide bonds in receptors for vasoactive intestinal peptide and secretin in rat pancreatic plasma membranes. Robberecht P; Waelbroeck M; Camus JC; De Neef P; Christophe J Biochim Biophys Acta; 1984 Jun; 773(2):271-8. PubMed ID: 6329286 [TBL] [Abstract][Full Text] [Related]
13. Secretin receptor activity in rat gastric glands. Binding studies, cAMP generation and pharmacology. Gespach C; Bataille D; Vauclin N; Moroder L; Wünsch E; Rosselin G Peptides; 1986; 7 Suppl 1():155-63. PubMed ID: 3018694 [TBL] [Abstract][Full Text] [Related]
14. Characterization of binding sites for VIP-related peptides and activation of adenylate cyclase in developing pancreas. Le Meuth V; Farjaudon N; Bawab W; Chastre E; Rosselin G; Guilloteau P; Gespach C Am J Physiol; 1991 Feb; 260(2 Pt 1):G265-74. PubMed ID: 1847591 [TBL] [Abstract][Full Text] [Related]
15. Structural requirements for VIP interaction with specific receptors in human and rat intestinal membranes: effect of nine partial sequences. Couvineau A; Rouyer-Fessard C; Fournier A; St Pierre S; Pipkorn R; Laburthe M Biochem Biophys Res Commun; 1984 Jun; 121(2):493-8. PubMed ID: 6329205 [TBL] [Abstract][Full Text] [Related]
17. Properties of vasoactive intestinal peptide-receptor interaction in rat liver membranes. Guerrero JM; Prieto JC; Ramírez-Cárdenas R; Calvo JR; Goberna R Rev Esp Fisiol; 1981 Mar; 37(1):1-8. PubMed ID: 6113623 [TBL] [Abstract][Full Text] [Related]
18. Secretin binding sites coupled with adenylate cyclase in rat fundic membranes. Gespach C; Bataille D; Vauclin N; Rosselin G; Moroder L; Wünsch E Peptides; 1981; 2 Suppl 2():247-51. PubMed ID: 6283494 [TBL] [Abstract][Full Text] [Related]
19. Vasoactive intestinal peptide receptors in pancreas and liver. Structure-function relationship. Christophe J; Svoboda M; Waelbroeck M; Winand J; Robberecht P Ann N Y Acad Sci; 1988; 527():238-56. PubMed ID: 2839079 [TBL] [Abstract][Full Text] [Related]
20. Interaction of GRF with VIP receptors and stimulation of adenylate cyclase in rat and human intestinal epithelial membranes. Comparison with PHI and secretin. Laburthe M; Amiranoff B; Boige N; Rouyer-Fessard C; Tatemoto K; Moroder L FEBS Lett; 1983 Aug; 159(1-2):89-92. PubMed ID: 6307754 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]